SHUTTLE PHARMACEUTICALS HOLDINGS, INC.: cashflow_financing
| Value | {"amount": 10578865, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:52:40.858116+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/34997de7-9de2-427f-be63-9a6b38957958
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001493152-24-034898Retrieved: 2026-08-19T17:52:40.858116+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001757499/cashflow-financing/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/34997de7-9de2-427f-be63-9a6b38957958
History
- supersedes {"amount": 10622908, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} (evidence 0001493152-23-007686)